Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Ebola Doctor: Media, Politicians Fueled the Public’s Fear

By Drug Discovery Trends Editor | February 27, 2015

In this Nov. 11, 2014, file photo, Dr. Craig Spencer, who was the first Ebola patient in New York City, listens to comments during a news conference at New York's Bellevue Hospital. Spencer says his activities before he was hospitalized were widely reported and criticized, but little attention was paid to the science of disease transmission. He said experience suggested it was nearly impossible for him to transmit the virus before he had a fever. Spencer made the remarks in an article published Wednesday, Feb. 25, 2015, in The New England Journal of Medicine. (AP Photo/Richard Drew)A doctor who contracted the deadly Ebola virus and rode the subway system and dined out before he developed symptoms said the media and politicians could have done a better job by educating people on the science of it instead of focusing on their fears.

“When we look back on this epidemic, I hope we’ll recognize that fear caused our initial hesitance to respond – and caused us to respond poorly when we finally did,” Dr. Craig Spencer wrote in an article published Wednesday in The New England Journal of Medicine.

Spencer, an emergency room physician, was diagnosed with Ebola on Oct. 23, days after returning from treating patients in Guinea with Doctors Without Borders. His was the first Ebola case in the nation’s largest city, spurring an effort to contain anxieties along with the virus. He was treated at a hospital, recovered and was released on Nov. 11.

News of Spencer’s infection unnerved some New York residents, particularly after they learned that he rode the subway system, ate out and went bowling in the days before he developed a fever and tested positive.

Spencer said little attention was devoted to the fact the science of disease transmission and the experience of previous Ebola outbreaks suggested it was “nearly impossible for me to have transmitted the virus before I had a fever.”

“Meanwhile, politicians, caught up in the election season, took advantage of the panic to try to appear presidential instead of supporting a sound, science-based public health response,” he said.

After Spencer’s diagnosis, New York Gov. Andrew Cuomo and New Jersey Gov. Chris Christie announced mandatory 21-day quarantines for travelers who have come in close contact with Ebola, which has infected more than 14,000 people in West Africa and has killed more than 5,000.

Cuomo and Christie called federal health guidelines inadequate when they announced their quarantine plans.

But the governors, Spencer said, did not “sufficiently consider the unintended side effects.”

The threat of quarantine may cause sick people to defer seeking treatment or cause health care responders returning from affected countries to “alter their travel plans or misreport their exposure to avoid quarantine,” said Spencer, whose treatment included a transfusion of blood plasma from another Ebola survivor.

“We all lose when we allow irrational fear, fueled in part by prime-time ratings and political expediency, to supersede pragmatic public health preparedness,” Spencer wrote.

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Chemical formula of psilocybin
Psychedelic pioneer Compass files for FDA approval as rivals close in
Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027
If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE